EMEA press release: CHMP adopted a positive opinion for pandemic influenza vaccine H5N1 (Celvapan)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE  SUMMARY OF POSITIVE OPINION for CELVAPAN Common Name: Pandemic Influenza Vaccine (H5N1 whole virion, Vero cell derived, inactivated) On 18 December 2008  the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion,  recommending the granting of a marketing authorisation for the medicinal product Celvapan, 7.5 […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos